NFKB1 and inflammatory bowel disease: In inflammatory bowel disease, the active inflamed tissue exhibits reduced Trib2 (TRIB2) expression, and Trib2 inhibits NF-κB activation mediated by Toll-like receptor 5 (TLR5) [34].